| Financial Year |
March 31 2023 |
| Monetary Funds |
69,563,297.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
61,863,317.58 |
| Advances to Suppliers |
11,947,004.22 |
| Other Receivables |
8,446,582.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,196,827.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,707,242.24 |
| Total Current Assets |
167,724,272.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
5,992,957.34 |
| Fixed Assetes |
595,208,478.02 |
| Under-construction Projects |
56,900,812.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
177,701,049.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,985,251.69 |
| Deferred Income Tax Assets |
46,296,523.46 |
| Other Non-Current Assets |
5,062,864.09 |
| Sub-Total of Non-Current Assets |
900,652,836.64 |
| Total Assets |
1,068,377,108.88 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
26,614,319.88 |
| Accounts Received In Advance |
30,746.69 |
| Employee Compensation Payable |
31,288,002.52 |
| Taxes Payable |
2,743,400.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,460,551.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,196,714.64 |
| Other Current Liabilities |
36,567.96 |
| Sub-Total of Current Liabilities |
87,916,904.43 |
| Long-term Loans |
74,999,258.54 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
78,677,761.70 |
| Total Liabilities |
166,594,666.13 |
| Paid-In Capital(Or Share Stock) |
266,670,000.00 |
| Capital Surplus |
285,558,450.64 |
| Surplus Reserve |
68,475,324.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
269,990,382.94 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
901,782,442.75 |
| Owner's Equity（Stockholder's Equity） |
901,782,442.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,068,377,108.88 |
